Bartlett & Co’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $50.6M | Buy |
222,687
+4,375
| +2% | +$919K | 0.82% | 42 |
|
|
2023
Q3 | $43.9M | Sell |
218,312
-25,186
| -10% | -$5.31M | 0.79% | 43 |
|
|
2023
Q2 | $50.5M | Buy |
243,498
+3,759
| +2% | +$729K | 0.87% | 35 |
|
|
2023
Q1 | $47.3M | Buy |
239,739
+2,920
| +1% | +$601K | 0.91% | 35 |
|
|
2022
Q4 | $47.9M | Buy |
236,819
+15,472
| +7% | +$3.02M | 0.96% | 34 |
|
|
2022
Q3 | $38.9M | Buy |
221,347
+7,435
| +3% | +$1.52M | 0.84% | 39 |
|
|
2022
Q2 | $43.1M | Buy |
213,912
+16,853
| +9% | +$3.59M | 0.87% | 41 |
|
|
2022
Q1 | $44.6M | Buy |
197,059
+2,001
| +1% | +$471K | 0.78% | 43 |
|
|
2021
Q4 | $52.7M | Buy |
195,058
+4,392
| +2% | +$1.09M | 0.89% | 37 |
|
|
2021
Q3 | $46.1M | Sell |
190,666
-8,797
| -4% | -$2.22M | 0.88% | 42 |
|
|
2021
Q2 | $47.3M | Sell |
199,463
-12,250
| -6% | -$2.79M | 0.9% | 43 |
|
|
2021
Q1 | $46.4M | Buy |
211,713
+620
| +0.3% | +$124K | 0.93% | 39 |
|
|
2020
Q4 | $36.9M | Buy |
211,093
+6,593
| +3% | +$1.14M | 0.79% | 45 |
|
|
2020
Q3 | $33.1M | Buy |
204,500
+920
| +0.5% | +$146K | 0.78% | 47 |
|
|
2020
Q2 | $29.1M | Buy |
203,580
+2,607
| +1% | +$361K | 0.76% | 45 |
|
|
2020
Q1 | $21.8M | Buy |
+200,973
| New | +$29M | 0.67% | 46 |
|
|
2019
Q3 | $30.3M | Buy |
209,979
+2,366
| +1% | +$345K | 0.8% | 42 |
|
|
2019
Q2 | $30.8M | Buy |
207,613
+523
| +0.3% | +$73K | 1.15% | 33 |
|
|
2019
Q1 | $27.2M | Buy |
207,090
+9,735
| +5% | +$1.2M | 1.04% | 36 |
|
|
2018
Q4 | $21.4M | Buy |
197,355
+5,026
| +3% | +$673K | 0.91% | 44 |
|
|
2018
Q3 | $28.7M | Buy |
192,329
+16,182
| +9% | +$2.46M | 1.08% | 36 |
|
|
2018
Q2 | $27.2M | Buy |
176,147
+161
| +0.1% | +$24.3K | 1.1% | 34 |
|
|
2018
Q1 | $24.5M | Buy |
175,986
+14,071
| +9% | +$2.07M | 1.01% | 40 |
|
|
2017
Q4 | $22.2M | Buy |
161,915
+1,214
| +0.8% | +$160K | 0.88% | 46 |
|
|
2017
Q3 | $20.8M | Sell |
160,701
-136
| -0.1% | -$18.1K | 0.87% | 46 |
|
|
2017
Q2 | $21.3M | Sell |
160,837
-3,572
| -2% | -$437K | 0.96% | 40 |
|
|
2017
Q1 | $20.3M | Sell |
164,409
-1,687
| -1% | -$200K | 0.92% | 41 |
|
|
2016
Q4 | $18.3M | Buy |
166,096
+5,715
| +4% | +$635K | 0.86% | 41 |
|
|
2016
Q3 | $18.9M | Sell |
160,381
-4,358
| -3% | -$514K | 0.91% | 43 |
|
|
2016
Q2 | $18.4M | Buy |
164,739
+3,475
| +2% | +$374K | 0.91% | 45 |
|
|
2016
Q1 | $16.2M | Buy |
161,264
+3,270
| +2% | +$314K | 0.81% | 46 |
|
|
2015
Q4 | $16.8M | Buy |
157,994
+2,832
| +2% | +$292K | 0.87% | 42 |
|
|
2015
Q3 | $14.5M | Buy |
155,162
+8,834
| +6% | +$914K | 0.79% | 47 |
|
|
2015
Q2 | $15.2M | Buy |
146,328
+15,198
| +12% | +$1.58M | 0.76% | 47 |
|
|
2015
Q1 | $14.2M | Buy |
131,130
+2,586
| +2% | +$266K | 0.71% | 50 |
|
|
2014
Q4 | $11.9M | Buy |
128,544
+5,477
| +4% | +$484K | 0.57% | 55 |
|
|
2014
Q3 | $10.8M | Sell |
123,067
-13,057
| -10% | -$1.18M | 0.52% | 61 |
|
|
2014
Q2 | $12M | Sell |
136,124
-6,361
| -4% | -$551K | 0.58% | 59 |
|
|
2014
Q1 | $12M | Sell |
142,485
-71,182
| -33% | -$5.68M | 0.6% | 60 |
|
|
2013
Q4 | $16.8M | Sell |
213,667
-3,933
| -2% | -$335K | 0.84% | 49 |
|
|
2013
Q3 | $18.5M | Sell |
217,600
-4,785
| -2% | -$403K | 1% | 40 |
|
|
2013
Q2 | $19.1M | Buy |
+222,385
| New | +$18.5M | 1.05% | 39 |
|
Other funds holding LH
Bartlett & Co's LH Position: Q4 2023 in Review
Bartlett & Co increased its Labcorp (LH) stake by 2% in Q4 2023, buying an estimated $919K and bringing the position to 222,687 shares worth $50.6M. The position accounts for 0.82% of the portfolio, ranked #42.
Bartlett & Co first reported a position in LH in Q2 2013 and has held it in 42 quarters since. The position peaked at $52.7M in Q4 2021. 956 funds tracked by Wall St. Rank hold LH as of Q4 2023.
- Bartlett & Co held 222,687 shares of Labcorp worth $50.6M as of Q4 2023.
- Bartlett & Co bought 4,375 Labcorp shares in Q4 2023, an estimated $919K.
- Labcorp made up 0.82% of Bartlett & Co's portfolio in Q4 2023, its #42 holding.
- Bartlett & Co first reported a position in Labcorp in Q2 2013 and has held it in 42 quarters since.
- Bartlett & Co's Labcorp position peaked at $52.7M in Q4 2021.
- 956 funds tracked by Wall St. Rank held Labcorp as of Q4 2023.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.